Noevir Holdings Co., Ltd.TSE: 4928

Dividend Distribution from Retained Earnings

· MarketScreener


November 7, 2025

Trade name:

Noevir Holdings Co., Ltd.

Listing:

Tokyo Stock Exchange, Prime Market (Securities Code: 4928)

URL:

https://www.noevirholdings.co.jp/english/

Representative:

Takashi Okura, President and CEO

Contact:

Junya Baba, General Manager, Accounting

Tel. +81-78-303-5121

Dividend Distribution from Retained Earnings

Noevir Holdings approved the distribution of dividends from retained earnings, as detailed below, at the Board of Directors' Meeting held on November 7, 2025. September 30, 2025 has been designated as the record date of this distribution.

  1. Dividend details

    Dividend decided

    Most recent

    dividend forecast (November 8, 2024)

    Previous distribution (2024 fiscal year)

    Record date

    September 30, 2025

    Same as left

    September 30, 2024

    Dividend per share

    230.00 yen

    225.00 yen

    225.00 yen

    Total amount of distribution

    7,855 million yen

    -

    7,685 million yen

    Effective date

    December 10, 2025

    -

    December 10, 2024

    Source of distribution

    Retained earnings

    -

    Retained earnings

  2. Reason for distribution

Noevir Holdings considers the return of profits to shareholders to be a crucial management priority. Therefore, Noevir Holdings' fundamental policy is to continuously distribute dividends to shareholders while maintaining the internal reserves necessary to expand business and strengthen its management structure over the medium and long terms.

In accordance with the aforementioned policy, the ordinary year-end dividend for the fiscal year ended September 30, 2025 will increase by 5 yen from the most recent dividend forecast to 230 yen per share.

[Reference]

Details of annual dividend distribution

Dividend per share

Record date

Interim

End of year

Total

2025 fiscal year results

None

230.00 yen

230.00 yen

2024 fiscal year results

None

225.00 yen

225.00 yen

Earlier from Noevir

All Noevir news releases